{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:00:19Z","timestamp":1778562019806,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00105-021-04833-1","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T11:02:41Z","timestamp":1623841361000},"page":"892-899","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Einfluss einer adjuvanten Basistherapie mit 10\u202f% Urea, Ceramiden, Glycerin und Glyceryl Glucoside bei Patienten mit Psoriasis vulgaris","Influence of an adjuvant treatment with an emollient containing 10\u202f% urea, ceramides, glycerin und glyceryl glucoside in patients with psoriasis vulgaris"],"prefix":"10.1007","volume":"72","author":[{"given":"Sophia","family":"von Martial","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gesa","family":"Nippel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel","family":"Sammain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sch\u00f6lermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Presto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Tsianakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"4833_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00403-016-1637-8","volume":"308","author":"M Augustin","year":"2016","unstructured":"Augustin\u00a0M, Eissing\u00a0L, Langenbruch\u00a0A et\u00a0al (2016) The German National Program on Psoriasis Health Care 2005\u20132015: results and experiences. Arch Dermatol Res 308:389\u2013400","journal-title":"Arch Dermatol Res"},{"key":"4833_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ddg.13580","volume":"4","author":"M Augustin","year":"2018","unstructured":"Augustin\u00a0M, Wilsmann-Theis\u00a0D, K\u00f6rber\u00a0A et al (2018) Positionspapier: Diagnostik und Therapie der Xerosis cutis. J\u00a0Dtsch Dermatol Ges 4:3\u201335","journal-title":"J Dtsch Dermatol Ges"},{"key":"4833_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","volume":"84","author":"C Elmets","year":"2021","unstructured":"Elmets\u00a0C, Korman\u00a0N, Prater\u00a0E et al (2021) Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J\u00a0Am Acad Dermatol 84:432\u2013470","journal-title":"J Am Acad Dermatol"},{"key":"4833_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.clindermatol.2008.01.015","volume":"26","author":"J Fluhr","year":"2008","unstructured":"Fluhr\u00a0J, Cavallotti\u00a0C, Berardesca\u00a0E (2008) Emollients, moisturizers, and keratolytic agents in psoriasis. Clin Dermatol 26:380\u2013386","journal-title":"Clin Dermatol"},{"key":"4833_CR5","first-page":"633","volume":"15","author":"A Friedman","year":"2016","unstructured":"Friedman\u00a0A, von Grote\u00a0E, Meckfessel\u00a0M (2016) Urea: a\u00a0clinically oriented overview from bench to bedside. J\u00a0Drugs Dermatol 15:633\u2013639","journal-title":"J Drugs Dermatol"},{"key":"4833_CR6","first-page":"797","volume":"37","author":"L Gip","year":"1985","unstructured":"Gip\u00a0L, Lundberg\u00a0M (1985) A double-blind controlled trial of a\u00a0new antipsoriatic cream containing urea and sodium chloride. Curr Ther Res 37:797\u2013804","journal-title":"Curr Ther Res"},{"key":"4833_CR7","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/jid.2012.42","volume":"132","author":"S Grether-Beck","year":"2012","unstructured":"Grether-Beck\u00a0S, Felsner\u00a0I, Brenden\u00a0H et al (2012) Urea uptake enhances barrier function and antimicrobial defense in humans by regulating gene expression. J\u00a0Invest Dermatol 132:1561\u20131572","journal-title":"J Invest Dermatol"},{"key":"4833_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2340\/0001555576353356","volume":"76","author":"I Hagemann","year":"1996","unstructured":"Hagemann\u00a0I, Proksch\u00a0E (1996) Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis. Acta Derm Venereol 76:353\u2013356","journal-title":"Acta Derm Venereol"},{"key":"4833_CR9","first-page":"5","volume":"19","author":"S Harcharik","year":"2014","unstructured":"Harcharik\u00a0S, Emer\u00a0J (2014) Steroid-sparing properties of emollients in dermatology. Skin Therapy Lett 19:5\u201310","journal-title":"Skin Therapy Lett"},{"key":"4833_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13555-015-0068-3","volume":"5","author":"A Jacobi","year":"2015","unstructured":"Jacobi\u00a0A, Mayer\u00a0A, Augustin\u00a0M (2015) Keratolytics and emollients and their role in the therapy of psoriasis: a\u00a0systematic review. Dermatol Ther 5:1\u201318","journal-title":"Dermatol Ther"},{"key":"4833_CR11","volume-title":"10\u202f% urea-containing body lotion improves subjective and objective symptoms of patients suffering from mild to moderate psoriasis: results of a\u00a04-weeks-treatment in vivo study","author":"K Jung","year":"2015","unstructured":"Jung\u00a0K, Buck\u00a0B, Benner\u00a0G et al (2015) 10\u202f% urea-containing body lotion improves subjective and objective symptoms of patients suffering from mild to moderate psoriasis: results of a\u00a04-weeks-treatment in vivo study. 23rd World Congress of Dermatology, Vancouver"},{"key":"4833_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ddg.13810","volume":"4","author":"A K\u00f6rber","year":"2019","unstructured":"K\u00f6rber\u00a0A, Wilsmann-Theis\u00a0D, Augustin\u00a0M et al (2019) Topische Therapie bei Psoriasis vulgaris \u2013 ein Behandlungspfad. J\u00a0Dtsch Dermatol Ges 4:3\u201314","journal-title":"J Dtsch Dermatol Ges"},{"key":"4833_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00403-016-1651-x","volume":"308","author":"A Langenbruch","year":"2016","unstructured":"Langenbruch\u00a0A, Radtke\u00a0M, Jacobi\u00a0A et\u00a0al (2016) Quality of psoriasis care in Germany: results of the national health care study \u201ePsoHealth3\u201c. Arch Dermatol Res 308:401\u2013408","journal-title":"Arch Dermatol Res"},{"key":"4833_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3346\/jkms.2006.21.1.95","volume":"2","author":"B Lew","year":"2006","unstructured":"Lew\u00a0B, Cho\u00a0Y, Kim\u00a0J et\u00a0al (2006) Ceramides and cell signaling molecules in psoriatric epidermis: reduced levels of ceramides. J\u00a0Korean Med Sci 2:95\u201399","journal-title":"J Korean Med Sci"},{"issue":"2","key":"4833_CR15","first-page":"186","volume":"34","author":"TY Lin","year":"2011","unstructured":"Lin\u00a0TY, See\u00a0LC, Shen\u00a0YM et\u00a0al (2011) Qualitiy of life in patients with psoriasis in northern Taiwan. Chang Gung Med\u00a0J 34(2):186\u2013196","journal-title":"Chang Gung Med J"},{"key":"4833_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/dth.12259","volume":"28","author":"M Liu","year":"2015","unstructured":"Liu\u00a0M, Li\u00a0X, Chen\u00a0X et al (2015) Topical application of a\u00a0linoleic acid-ceramide containing moisturizer exhibit therapeutic and preventive benefits for psoriasis vulgaris: a\u00a0randomized controlled trial. Dermatol Ther 28:373\u2013382","journal-title":"Dermatol Ther"},{"key":"4833_CR17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2165\/00128071-200304110-00005","volume":"4","author":"M Loden","year":"2003","unstructured":"Loden\u00a0M (2003) Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol 4:771\u2013788","journal-title":"Am J Clin Dermatol"},{"key":"4833_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1684\/ejd.2014.2294","volume":"24","author":"T Luger","year":"2014","unstructured":"Luger\u00a0T, Seite\u00a0S, Humbert\u00a0P et\u00a0al (2014) Recommendations for adjunctive basic skin care in patients with psoriasis. Eur J Dermatol 24:194\u2013200","journal-title":"Eur J Dermatol"},{"key":"4833_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaad.2014.01.891","volume":"71","author":"M Meckfessel","year":"2014","unstructured":"Meckfessel\u00a0M, Brandt\u00a0S (2014) The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products. J\u00a0Am Acad Dermatol 71:177\u2013184","journal-title":"J Am Acad Dermatol"},{"key":"4833_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0925-4439(93)90135-N","volume":"1182","author":"S Motta","year":"1993","unstructured":"Motta\u00a0S, Monti\u00a0M, Sesana\u00a0S et\u00a0al (1993) Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1182:147\u2013151","journal-title":"Biochim Biophys Acta"},{"key":"4833_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","volume":"303","author":"U Mrowietz","year":"2011","unstructured":"Mrowietz\u00a0U, Kragballe\u00a0K, Reich\u00a0K et\u00a0al (2011) Definition of treatment goals for moderate to severe psoriasis: a\u00a0European consensus. Arch Dermatol Res 303:1\u201310","journal-title":"Arch Dermatol Res"},{"key":"4833_CR22","first-page":"645","volume":"16","author":"A Nast","year":"2018","unstructured":"Nast\u00a0A, Amelunxen\u00a0L, Augustin\u00a0M et al (2018) S3-Leitlinie zur Therapie der Psoriasis vulgaris Update \u2013 Kurzfassung Teil 1 \u2013 Systemische Therapie. J\u00a0Dtsch Dermatol Ges 16:645\u2013670","journal-title":"J Dtsch Dermatol Ges"},{"key":"4833_CR23","first-page":"20392","volume":"19","author":"M Pan","year":"2013","unstructured":"Pan\u00a0M, Heinecke\u00a0G, Bernardo\u00a0S et\u00a0al (2013) Urea: a\u00a0comprehensive review of the clinical literature. Dermatol Online\u00a0J 19:20392","journal-title":"Dermatol Online J"},{"key":"4833_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ad.2013.02.009","volume":"105","author":"S Ros","year":"2014","unstructured":"Ros\u00a0S, Puig\u00a0L, Carrascosa\u00a0J (2014) Cumulative life course impairment: the imprint of psoriasis on the patient\u2019s life. Actas Dermosifiliogr 105:128\u2013134","journal-title":"Actas Dermosifiliogr"},{"key":"4833_CR25","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/j.1600-0625.2009.00903.x","volume":"18","author":"S Seite","year":"2009","unstructured":"Seite\u00a0S, Khemis\u00a0A, Rougier\u00a0A et\u00a0al (2009) Emollient for maintenance therapy after topical corticotherapy in mild psoriasis. Exp Dermatol 18:1076\u20131078","journal-title":"Exp Dermatol"},{"issue":"1 Suppl 2","key":"4833_CR26","first-page":"32","volume":"79","author":"L Stein Gold","year":"2007","unstructured":"Stein Gold\u00a0L, Corvari\u00a0L (2007) The roles of safety and compliance in determining effectiveness of topical therapy for psoriasis. Cutis 79(1 Suppl 2):32\u201338","journal-title":"Cutis"},{"key":"4833_CR27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1046\/j.1087-0024.2003.09102.x","volume":"9","author":"R Stern","year":"2004","unstructured":"Stern\u00a0R, Nijsten\u00a0T, Feldman\u00a0S et\u00a0al (2004) Psoriasis is common, carries a\u00a0substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J\u00a0Investig Dermatol Symp Proc 9:136\u2013139","journal-title":"J Investig Dermatol Symp Proc"},{"key":"4833_CR28","first-page":"415","volume":"13","author":"D Tha\u00e7i","year":"2015","unstructured":"Tha\u00e7i\u00a0D, Augustin\u00a0M, Krutmann\u00a0J et\u00a0al (2015) Importance of basic therapy in psoriasis. J\u00a0Dtsch Dermatol Ges 13:415\u2013418","journal-title":"J Dtsch Dermatol Ges"},{"key":"4833_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/jdv.16691","volume":"6","author":"M Thouvenin","year":"2020","unstructured":"Thouvenin\u00a0M, Dalmon\u00a0S, Theunis\u00a0J et al (2020) Tolerance and efficacy of a\u00a0new celastrol-containing balm as adjunct care in psoriasis. J\u00a0Eur Acad Dermatol Venereol 6:10\u201316","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4833_CR30","first-page":"383","volume":"50","author":"K Watsky","year":"1992","unstructured":"Watsky\u00a0K, Freije\u00a0L, Leneveu\u00a0M et al (1992) Water-in-oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis. Cutis 50:383\u2013386","journal-title":"Cutis"},{"key":"4833_CR31","first-page":"29","volume":"5","author":"T Weber","year":"2012","unstructured":"Weber\u00a0T, Kausch\u00a0M, Rippke\u00a0F et\u00a0al (2012) Treatment of xerosis with a\u00a0topical formulation containing glyceryl glucoside, natural moisturizing factors, and ceramide. J\u00a0Clin Aesthet Dermatol 5:29\u201339","journal-title":"J Clin Aesthet Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04833-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04833-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04833-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T23:19:49Z","timestamp":1699139989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04833-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["4833"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04833-1","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"10 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0von Martial gibt an, dass kein Interessenkonflikt besteht. G.\u00a0Nippel, L.\u00a0Schmidt, A.\u00a0Sammain, A.\u00a0Sch\u00f6lermann und S.\u00a0Presto sind Mitarbeiter der Beiersdorf\u00a0AG. A.\u00a0Tsianakas ist Pr\u00fcfarzt der klinischen Pr\u00fcfung.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Alle beschriebenen Untersuchungen am Menschen oder an menschlichem Gewebe wurden mit Zustimmung der zust\u00e4ndigen Ethikkommission, im Einklang mit nationalem Recht sowie gem\u00e4\u00df der Deklaration von Helsinki von 1975 (in der aktuellen, \u00fcberarbeiteten Fassung) durchgef\u00fchrt. Von allen beteiligten Patienten liegt eine Einverst\u00e4ndniserkl\u00e4rung vor. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}